Close

Rating History for Horizon Therapeutics (HZNP) by Piper Sandler

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/12/2022 David Amsellem Downgrade Neutral
(Overweight)
116.50
(110.00)
97.29
(116.30)
19.54% Details